The resignation of Chris Viehbacher as chief executive officer of Sanofi raises questions in New York where Sanofi has invested $700 million since June buying stock in New York drug developer Regeneron, which employs 900 in the Albany region. So news that Christopher A. Viehbacher has resigned as CEO of Sanofi warrants attention from Albany communities built around 900 high-paying jobs at Regeneron.